Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

Analysis of Liquidity Ratios 
Quarterly Data

Microsoft Excel

Liquidity Ratios (Summary)

CVS Health Corp., liquidity ratios (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Current ratio 0.80 0.86 0.81 0.86 0.86 0.86 0.92 0.94 0.94 0.91 0.88 0.88 0.94 0.95 0.93 0.91 0.95 0.98 0.99 0.94 0.92 0.95 0.95
Quick ratio 0.54 0.60 0.54 0.59 0.60 0.59 0.61 0.62 0.64 0.62 0.54 0.55 0.59 0.58 0.54 0.53 0.58 0.63 0.60 0.52 0.52 0.54 0.55
Cash ratio 0.11 0.20 0.16 0.14 0.20 0.21 0.24 0.23 0.28 0.22 0.16 0.18 0.20 0.17 0.15 0.18 0.19 0.27 0.21 0.15 0.14 0.17 0.16

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. CVS Health Corp. current ratio improved from Q1 2024 to Q2 2024 but then deteriorated significantly from Q2 2024 to Q3 2024.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. CVS Health Corp. quick ratio improved from Q1 2024 to Q2 2024 but then deteriorated significantly from Q2 2024 to Q3 2024.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. CVS Health Corp. cash ratio improved from Q1 2024 to Q2 2024 but then deteriorated significantly from Q2 2024 to Q3 2024.

Current Ratio

CVS Health Corp., current ratio calculation (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selected Financial Data (US$ in millions)
Current assets 67,343 69,952 67,473 67,858 70,143 67,756 68,706 65,682 68,341 62,142 61,483 60,008 60,842 56,559 55,719 56,369 59,211 62,506 58,958 50,302 48,185 46,901 47,857
Current liabilities 84,627 81,386 83,319 79,189 81,553 79,206 75,054 69,736 72,409 68,457 69,780 67,807 64,709 59,311 60,104 62,017 62,044 63,694 59,560 53,303 52,544 49,376 50,631
Liquidity Ratio
Current ratio1 0.80 0.86 0.81 0.86 0.86 0.86 0.92 0.94 0.94 0.91 0.88 0.88 0.94 0.95 0.93 0.91 0.95 0.98 0.99 0.94 0.92 0.95 0.95
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories 1.60 1.68 1.60 1.64 1.74 1.64 1.68 1.63 1.86 2.01 1.85 1.85 1.83 1.79 1.75 1.72 1.70 1.57 1.43 1.44 1.54 1.68 1.58
Cigna Group 0.86 0.83 0.83 0.77 0.73 0.73 0.72 0.73 0.73 0.83 0.81 0.83 0.70 0.72 0.76 0.77 0.79 0.83 0.76 0.74 0.61 0.65 0.64
Elevance Health Inc. 1.50 1.49 1.37 1.44 1.41 1.44 1.43 1.40 1.35 1.36 1.36 1.47 1.48 1.49 1.57 1.55 1.59 1.64 1.53 1.65 1.70 1.64 1.61
Humana Inc. 1.76 1.66 1.67 1.59 1.37 1.37 1.39 1.52 1.35 1.53 1.53 1.62 1.72 1.71 1.67 1.77 1.81 1.69 1.66 1.82 1.83 1.75 1.65
Intuitive Surgical Inc. 4.30 5.15 5.55 4.76 5.31 5.22 5.26 4.40 5.10 5.36 5.22 5.08 5.58 5.99 6.71 6.86 7.04 6.38 4.96 4.53 4.64 5.04 5.44
Medtronic PLC 2.30 2.29 2.42 2.39 1.76 1.76 1.58 1.86 2.61 2.91 2.89 2.65 2.10 2.16 1.87 2.13 2.75 2.77 2.67 2.59 2.36 2.56 2.46
UnitedHealth Group Inc. 0.91 0.88 0.85 0.79 0.80 0.80 0.81 0.77 0.82 0.77 0.78 0.79 0.77 0.77 0.74 0.74 0.82 0.84 0.75 0.69 0.70 0.67 0.73

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

1 Q3 2024 Calculation
Current ratio = Current assets ÷ Current liabilities
= 67,343 ÷ 84,627 = 0.80

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. CVS Health Corp. current ratio improved from Q1 2024 to Q2 2024 but then deteriorated significantly from Q2 2024 to Q3 2024.

Quick Ratio

CVS Health Corp., quick ratio calculation (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selected Financial Data (US$ in millions)
Cash and cash equivalents 6,875 12,507 9,801 8,196 13,043 13,807 14,618 12,945 17,197 12,116 8,442 9,408 9,826 7,119 5,598 7,854 9,256 14,869 10,081 5,683 5,193 6,063 5,896
Short-term investments 2,805 3,755 3,288 3,259 3,145 3,080 3,102 2,778 2,792 2,877 2,900 3,117 3,015 3,006 3,190 3,000 2,831 2,596 2,632 2,373 2,334 2,462 2,426
Accounts receivable, net 36,179 32,385 32,217 35,227 32,927 29,546 28,331 27,276 26,317 27,233 26,451 24,431 25,283 24,164 23,855 21,742 23,816 22,520 23,037 19,617 19,789 18,174 19,509
Total quick assets 45,859 48,647 45,306 46,682 49,115 46,433 46,051 42,999 46,306 42,226 37,793 36,956 38,124 34,289 32,643 32,596 35,903 39,985 35,750 27,673 27,316 26,699 27,831
 
Current liabilities 84,627 81,386 83,319 79,189 81,553 79,206 75,054 69,736 72,409 68,457 69,780 67,807 64,709 59,311 60,104 62,017 62,044 63,694 59,560 53,303 52,544 49,376 50,631
Liquidity Ratio
Quick ratio1 0.54 0.60 0.54 0.59 0.60 0.59 0.61 0.62 0.64 0.62 0.54 0.55 0.59 0.58 0.54 0.53 0.58 0.63 0.60 0.52 0.52 0.54 0.55
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories 1.00 1.02 0.95 1.00 1.04 1.00 1.07 1.06 1.22 1.33 1.21 1.28 1.25 1.19 1.16 1.14 1.01 0.93 0.83 0.88 0.93 0.98 0.94
Cigna Group 0.61 0.60 0.58 0.54 0.61 0.61 0.59 0.58 0.61 0.52 0.48 0.48 0.58 0.59 0.64 0.66 0.46 0.50 0.42 0.41 0.51 0.53 0.53
Elevance Health Inc. 1.34 1.32 1.23 1.30 1.29 1.32 1.31 1.27 1.21 1.22 1.23 1.33 1.33 1.35 1.43 1.42 1.45 1.49 1.37 1.52 1.58 1.51 1.49
Humana Inc. 1.40 1.37 1.35 1.24 1.15 1.16 1.18 1.20 1.13 1.21 1.21 1.20 1.32 1.28 1.26 1.37 1.47 1.35 1.29 1.47 1.51 1.36 1.32
Intuitive Surgical Inc. 3.21 3.94 4.31 3.83 4.44 4.36 4.30 3.56 4.19 4.49 4.40 4.34 4.66 5.12 5.76 5.96 5.93 5.40 4.00 3.75 3.80 4.15 4.53
Medtronic PLC 1.46 1.42 1.51 1.54 1.18 1.18 1.01 1.30 1.87 2.07 2.06 1.91 1.58 1.63 1.37 1.50 2.05 2.02 1.95 1.90 1.69 1.88 1.83
UnitedHealth Group Inc. 0.83 0.81 0.79 0.73 0.75 0.74 0.75 0.70 0.77 0.71 0.72 0.72 0.71 0.71 0.68 0.68 0.75 0.76 0.66 0.63 0.64 0.62 0.66

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

1 Q3 2024 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 45,859 ÷ 84,627 = 0.54

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. CVS Health Corp. quick ratio improved from Q1 2024 to Q2 2024 but then deteriorated significantly from Q2 2024 to Q3 2024.

Cash Ratio

CVS Health Corp., cash ratio calculation (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selected Financial Data (US$ in millions)
Cash and cash equivalents 6,875 12,507 9,801 8,196 13,043 13,807 14,618 12,945 17,197 12,116 8,442 9,408 9,826 7,119 5,598 7,854 9,256 14,869 10,081 5,683 5,193 6,063 5,896
Short-term investments 2,805 3,755 3,288 3,259 3,145 3,080 3,102 2,778 2,792 2,877 2,900 3,117 3,015 3,006 3,190 3,000 2,831 2,596 2,632 2,373 2,334 2,462 2,426
Total cash assets 9,680 16,262 13,089 11,455 16,188 16,887 17,720 15,723 19,989 14,993 11,342 12,525 12,841 10,125 8,788 10,854 12,087 17,465 12,713 8,056 7,527 8,525 8,322
 
Current liabilities 84,627 81,386 83,319 79,189 81,553 79,206 75,054 69,736 72,409 68,457 69,780 67,807 64,709 59,311 60,104 62,017 62,044 63,694 59,560 53,303 52,544 49,376 50,631
Liquidity Ratio
Cash ratio1 0.11 0.20 0.16 0.14 0.20 0.21 0.24 0.23 0.28 0.22 0.16 0.18 0.20 0.17 0.15 0.18 0.19 0.27 0.21 0.15 0.14 0.17 0.16
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories 0.52 0.52 0.47 0.53 0.54 0.57 0.66 0.66 0.74 0.75 0.65 0.78 0.75 0.71 0.67 0.60 0.46 0.46 0.34 0.38 0.41 0.37 0.36
Cigna Group 0.12 0.14 0.18 0.18 0.20 0.22 0.20 0.17 0.19 0.11 0.12 0.14 0.13 0.15 0.24 0.32 0.15 0.20 0.13 0.14 0.17 0.17 0.20
Elevance Health Inc. 0.90 0.86 0.82 0.87 0.90 0.92 0.91 0.86 0.87 0.86 0.86 0.95 0.97 0.97 1.08 1.04 1.04 1.10 0.95 1.08 1.14 1.07 1.04
Humana Inc. 1.29 1.16 1.15 1.13 1.09 1.11 1.06 1.10 1.07 1.02 1.02 1.08 1.20 1.12 1.12 1.29 1.39 1.22 1.16 1.37 1.44 1.28 1.15
Intuitive Surgical Inc. 2.52 3.20 3.49 3.15 3.86 3.77 3.59 2.90 3.50 3.78 3.58 3.66 3.98 4.42 5.04 5.30 5.27 4.85 3.44 3.13 3.11 3.37 3.79
Medtronic PLC 0.85 0.80 0.87 0.88 0.77 0.79 0.63 0.85 1.26 1.37 1.36 1.27 1.17 1.18 0.99 1.06 1.33 1.27 1.25 1.16 1.03 1.20 1.21
UnitedHealth Group Inc. 0.37 0.33 0.35 0.34 0.42 0.44 0.43 0.36 0.46 0.36 0.37 0.36 0.35 0.35 0.33 0.33 0.37 0.42 0.35 0.28 0.30 0.32 0.32

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

1 Q3 2024 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 9,680 ÷ 84,627 = 0.11

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. CVS Health Corp. cash ratio improved from Q1 2024 to Q2 2024 but then deteriorated significantly from Q2 2024 to Q3 2024.